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Abstract objective It has been suggested that Schistosoma mansoni, which is endemic in African fishing
communities, might increase susceptibility to human immunodeficiency virus (HIV) acquisition. If
confirmed, this would be of great public health importance in these high HIV-risk communities. This
study was undertaken to determine whether S. mansoni infection is a risk factor for HIV infection
among the fishing communities of Lake Victoria, Uganda. We conducted a matched case–control
study, nested within a prospective HIV incidence cohort, including 50 HIV seroconverters (cases) and
150 controls during 2009-2011.
methods S. mansoni infection prior to HIV seroconversion was determined by measuring serum
circulating anodic antigen (CAA) in stored serum. HIV testing was carried out using the Determine
rapid test and infection confirmed by enzyme-linked immunosorbent assays.
results About 49% of cases and 52% of controls had S. mansoni infection prior to HIV
seroconversion (or at the time of a similar study visit, for controls): odds ratio, adjusting for ethnicity,
religion, marital status, education, occupation, frequency of alcohol consumption in previous
3 months, number of sexual partners while drunk, duration of stay in the community, and history of
schistosomiasis treatment in the past 2 years was 1.23 (95% CI 0.3–5.7) P = 0.79. S. mansoni
infections were chronic (with little change in status between enrolment and HIV seroconversion), and
there was no difference in median CAA concentration between cases and controls.
conclusions These results do not support the hypothesis that S. mansoni infection promotes HIV
acquisition.
keywords Schistosoma mansoni, circulating anodic antigen, HIV, susceptibility, fishing communities,
Uganda
Introduction
Fishing communities in Uganda are disproportionately
affected by HIV infection with incidence and prevalence
four times the national average, or more [1, 2]. These fig-
ures are attributed to high-risk sexual behaviour and lim-
ited access to health services [1, 2]. Schistosoma mansoni,
a chronic, immunomodulating helminth infection, highly
prevalent in fishing communities, may be an additional
risk factor in these communities [3]. It is estimated that
over 16 million Ugandans are at risk of schistosomiasis
and more than 4 million infected [4].
S. haematobium is a potential risk factor for HIV
acquisition, because it directly affects the genital mucosa
[5]. S. mansoni infection has also been linked to
increased risk of acquiring simian–human immunodefi-
ciency virus (SHIV) and HIV in primate and human stud-
ies, respectively [3, 6, 7]. Proposed systemic
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immunological mechanisms for this include up-regulation
of HIV co-receptors and of Th2 T cells in which HIV
may replicate more efficiently [3, 8]. If confirmed, this
would imply that control of S. mansoni, as well as of
S. haematobium, could contribute to reducing the HIV
reservoir among fishing communities and hence spread to
the general population.
We conducted a matched case–control study, nested
within a prospective HIV incidence study, to determine
whether S. mansoni infection promotes HIV acquisition
in Ugandan fishing communities.
Methods
The study was conducted among five fishing communities
on Lake Victoria, Uganda. This was a matched case–control
study nested within a prospective HIV incidence cohort of
1000 individuals (males and females, aged 13–49 years)
recruited in 2009, and followed for 18 months [2].
Within the prospective cohort, data on risk factors for
HIV acquisition, and serum samples for HIV testing and
storage, were obtained at enrolment and at six-monthly
follow-up intervals. HIV testing was carried out using
Determine rapid tests (Abbott Laboratories, Chicago, IL,
USA), confirmed by enzyme-linked immunosorbent assays
(ELISA; Vironostika HIV Uni-Form II plus 0 microelisa
system, Biomerieux, Boxtel, Netherlands and Murex HIV-
1.2.0, Murex, Biotech Limited, Dartford, UK), with Wes-
tern blot (Calypte Biomedical Corporation, Rockville,
Maryland, USA) if ELISA results were indeterminate. Dur-
ing follow-up, 59 individuals became HIV-1 positive [2].
All cases available and willing to participate were
selected. Fifty HIV seroconverters were included as cases,
with 150 controls selected from those who remained HIV
negative. For every case, three controls matched on age,
sex and community of residence were randomly selected
by computer using StataSE12 (1985–2011 StataCorp,
College Station, TX, USA). Controls that were not will-
ing to participate or could not be traced after more than
three attempts were replaced.
At the case–control study visit, participants were inter-
viewed regarding schistosomiasis risk factors. Stored
serum was tested for Schistosoma circulating anodic anti-
gen (CAA) at cohort enrolment, 6, 12 and 18 months
using CAA-specific up-converting phosphor technology-
based lateral flow assay strips (UPT-LF) [9, 10], and a
CAA value ≥ 32 pg/ml was considered positive. Although
CAA cannot distinguish S. mansoni from S. haematobi-
um, the latter has not been found on the Ugandan shores
of Lake Victoria [11], so a positive result was taken as
indicative of S. mansoni infection. For cases, CAA sero-
status was taken as the result for the last sample before
HIV seroconversion. For controls, CAA serostatus was
taken as the result for the sample corresponding to the
last visit before HIV seroconversion for the matched case.
Stool samples were also collected during the case–con-
trol study visit (after the end of cohort follow-up), for
three consecutive days, to test for S. mansoni infection.
Two laboratories participated. Microscopy was per-
formed using the Kato–Katz method in one location, for-
mol–ether concentration in the other location. Intensity
of infection was defined based on WHO criteria as light
(<100 eggs per gram (epg), moderate (100–399 epg) and
heavy (≥400 epg).
Participants diagnosed with HIV infection (during fol-
low-up) were referred to The AIDS Support Organization
(TASO) and Entebbe Hospital for care and treatment
according to the Uganda Ministry of Health guidelines.
Those diagnosed with S. mansoni infection (after the end
of follow-up) were treated with single-dose praziquantel,
40 mg/kg. Participants diagnosed with other helminth
infections were treated with a single dose of albendazole
400 mg.
Data were double-entered using MS Access 2003
(1992–2003 Microsoft Corporation, Redmond, Washing-
ton, USA) and analysed using StataSE12.
The outcome was HIV seroconversion during follow-
up. The aim was to determine whether S. mansoni infec-
tion (assessed by serum CAA) was associated with the
outcome (HIV seroconversion during follow-up). Associa-
tions between stool microscopy results and serum CAA
were also investigated.
Baseline age, sex and community of residence were
matching factors. Matched conditional logistic regression
was used to investigate univariable associations between
HIV seroconversion and other demographic factors (mar-
ital status, education status, occupation, religion and
behavioural risk factors; being away from home for at
least two nights in the previous month; frequency of alco-
hol use; and number of sexual partners while under the
influence of alcohol or drugs during the previous
3 months) and to investigate risk factors for S. mansoni
infection (duration of stay in fishing community and his-
tory of treatment for schistosomiasis in the preceding
2 years). Covariates considered a priori to be potential
confounders (marital status, religion and ethnicity) and
those associated with S. mansoni at P ≤ 0.1 were
assessed for confounding by adding them individually to
the multivariable model and tested for goodness of fit
using log likelihood ratio test. If the S. mansoni–HIV
effect measure changed by 10% or more, the covariate
was retained in the final model.
The study was approved by Uganda Virus Research
Institute Science and Ethics Committee (FWA number
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00001354) and the Uganda National Council of Science
and Technology (FWA number 00001293). Participants
aged 18 years and above were enrolled after giving writ-
ten informed consent. Those aged 13–17 years were
enrolled after written assent, with consent from their par-
ents or guardians.
Results
Socio-demographic characteristics
Characteristics of the cohort have been described [2].
Among the 200 participants enrolled into this nested
study, median age was 25 years (IQR 22–30 years). The
highest proportion was males (56%), Roman Catholics
(41%), married (63%), with incomplete primary-level
education (41%) and worked in fishing-related jobs
(66%).
Schistosomiasis
The majority of participants (76%) had not received
S. mansoni (praziquantel) treatment in the previous
2 years. Determination of S. mansoni infection status was
based on serum CAA.
Half (51%) had S. mansoni infection at cohort enrol-
ment, 48%, 52% and 52% at 6, 12 and 18 months,
respectively. There was 96% agreement between the
CAA status at enrolment and CAA status at the pre-sero-
conversion (or equivalent control) time point (j=0.91,
P < 0.001). Compared to the stool results, serum CAA
had a sensitivity of 84%, specificity 92% and a positive
predictive value of 94%. Intensity of S. mansoni infection
was assessed in 79 samples examined by the Kato–Katz
method. Of those infected, 61% had light, 29% moder-
ate and 10% heavy infections.
S. mansoni prevalence was highest in the 25–29 years
age group, [66%, P < 0.001], higher among males than
females [75% vs. 21%, P < 0.001] and increased with
declining education level [P = 0.035]. Almost all partici-
pants who were engaged in fishing had S. mansoni infec-
tion [54/58, 93%; P < 0.001 compared to other
occupational groups]. Being away from home frequently
[P = 0.009] and long-term residence in the fishing com-
munity [P = 0.012] were associated with S. mansoni
infection.
Association between S. mansoni infection and HIV
acquisition
There was no difference between cases who acquired
HIV infection, and controls who had not, in S. mansoni
infection status based on CAA results at the preceding
visit: 49% of cases and 52% of controls had S. mansoni
infection [OR 0.83 (95% CI 0.39–1.77) P = 0.63]. The
result was similar after adjusting for ethnicity, religion,
marital status, education, occupation, frequency of alco-
hol consumption in previous 3 months, number of sexual
partners while drunk, duration of stay in the community
and history of schistosomiasis treatment (praziquantel) in
the past 2 years [aOR 1.23 (95% CI 0.3–5.7) P = 0.79].
There was also no difference in median CAA concentra-
tion between cases and controls: 2906 and 6530 pg/ml,
respectively (P = 0.16).
Factors associated with HIV acquisition in the case–
control study were similar to those previously reported
for the whole cohort: occupation, religion, frequency of
alcohol consumption (2); Table 1. In addition, not hav-
ing taken praziquantel treatment for Schistosomiasis in
the last 2 years was associated with HIV acquisition
[OR 8.25 (95% CI 1.3–51.1) P = 0.03].
Discussion and conclusion
We found that S. mansoni infection was not associated
with HIV acquisition among adults in Lake Victoria fish-
ing villages. As opposed to S. haematobium, S. mansoni
is unlikely to cause genital lesions. This result therefore
suggests that systemic immune modulation by S. mansoni
does not significantly increase susceptibility to HIV acqui-
sition.
By contrast, an experiment in macaques showed
increased susceptibility to a simian–human immunodefi-
ciency virus (SHIV) infection in S. mansoni-infected ani-
mals [6]. However, the macaque schistosome infections
were recent at the time of SHIV exposure (7 weeks),
egg counts were equivalent to moderate to heavy
human infections, and the virus was administered rec-
tally, encountering tissues directly affected by S. man-
soni egg-induced lesions. By contrast, our human
participants had chronic S. mansoni infections (few had
recently been treated, and status had not changed
between enrolment and the pre-seroconversion visit),
many had light infections, and HIV infection would
usually have occurred via the genital mucosa. Indeed,
in a second macaque study, S. mansoni infection did
not increase susceptibility when SHIV was administered
intravenously, implying that route of infection was
critical [7].
Cross-sectional studies have provided conflicting evi-
dence regarding HIV–S. mansoni associations. A survey
focussing on women on the Tanzanian shores of Lake
Victoria using serum CAA to determine Schistosoma
infection found a positive association with HIV infection,
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and higher CAA levels among HIV-positive women [12].
However, the number of HIV-infected women was small
(21 of 345) so confidence intervals were wide, the preva-
lence of HIV infection was approximately 4.5 times
lower than in the Ugandan fishing villages, and the catch-
ment area extended to 25 km from the lake, so that a
wide array of potential confounding factors in terms of
environment and lifestyle may have come into play. A
low prevalence of S. haematobium (3%) might also have
contributed.
The cross-sectional design of the Tanzanian study
means that the sequence in which the infections occurred
is unknown. An earlier study showed no positive associa-
tion between S. mansoni and HIV infection and high-
lighted differences in occupation and origin of members
of the population affected by the two infections [13].
Table 1 Multivariable conditional regression analysis of factors associated with HIV infection
Variable
Unadjusted Adjusted
OR 95% CI OR 95% CI P-value
Serum CAA 0.8 0.4–1.8 1.23 0.3–5.7 0.79
Marital status
Premarital 1 Ref 1 Ref 0.5
Married Monogamous 1.00 0.4–2.6 1.14 0.19–6.76
Married Polygamous 0.55 0.2–2.0 0.36 0.33–4.02
Divorced/Widowed 1.36 0.4–4.4 0.52 0.55-4.86
Education Status
Post-primary 1 Ref 1 Ref 0.94
Completed Primary 1.42 0.6–3.6 0.64 0.1–3.9
Incomplete Primary 1.20 0.5–2.8 0.94 0.2–5.2
None 1.61 0.5–5.3 1.00 0.1–8.5
Occupation
Fishing 1 Ref 1 Ref <0.005
Fishing related 1.13 0.4–3.1 13.54 1.8–101.3
Bar/Hotel/restaurant 2.92 0.6–15.1 41.53 1.6–1071.3
Business/trade 0.49 0.1–2.6 0.32 0.0–6.3
Farming 1.57 0.4–6.0 8.84 0.7–110.6
Other jobs 2.22 0.5–10.5 4.00 0.3–52.5
Not earning 1.85 – 4.78 –
Religion
Catholic 1 Ref 1 Ref 0.018
Anglican 5.56 2.3–13.5 7.98 1.8–35.4
Muslim 1.65 0.7–3.9 2.73 0.7–10.9
Other 1.70 0.4–7.2 9.06 0.7–112.3
Ethnicity
Non-Muganda 1 Ref 1 Ref 0.32
Muganda 0.8 0.4–1.6 0.50 0.1–2.0
Alcohol use
Never 1 Ref 1 Ref 0.013
Rarely 1.92 0.8–4.8 9.21 1.4–61.8
Regularly 3.49 1.6–7.8 6.85 1.3–37.4
Duration of stay
5–45 years 1 Ref 1 Ref <0.005
<5 years 3.77 1.6–8.6 7.56 1.5–37.6
Bilharzia treatment in last 2 years
Yes 1 Ref 1 Ref 0.034
No 2.49 1.0–6.3 8.25 1.3–51.1
Sexual partners while drunk(pre-infection)
0 1 Ref 1 Ref 0.98
1 1.96 0.8–4.7 0.67 0.1–3.2
≥ 2 1.58 0.4–6.0 0.48 0.0–7.0
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Given the lack of association we observed between
S. mansoni infection and HIV acquisition, we were sur-
prised to observe a strong association between HIV infec-
tion and lack of praziquantel treatment in the last
2 years. It is difficult to draw robust conclusions from
self-reported behaviour. We presume this may be a mar-
ker for poor health-seeking behaviour, rather than for a
biological process. Participants were not examined or
treated for S. mansoni by the research team during the
cohort study.
Strengths of our study were prospective sample collec-
tion, recruitment restricted to a relatively uniform (fishing
village) community, and matching and adjustment for
potential confounders. The CAA assay allowed assess-
ment of S. mansoni infection status at enrolment and
immediately prior to HIV seroconversion, demonstrating
chronicity of infection, and avoided potential concerns
about differential egg excretion among HIV-positive and
HIV-negative people [14]. Although it can be difficult to
assess causality in case–control studies, the prospective
design of our cohort did allow us to assess Schistosomia-
sis status prior to HIV acquisition – an important
improvement over studies with a cross-sectional design.
While there are many potential benefits of S. mansoni
control in heavily infected communities, our results sug-
gest that an impact on HIV transmission is not one of
them.
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